tiprankstipranks
Trending News
More News >
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market

CytoMed Therapeutics Limited (GDTC) Financial Statements

Compare
17 Followers

CytoMed Therapeutics Limited Financial Overview

CytoMed Therapeutics Limited's market cap is currently $10.97M. The company's EPS TTM is $-0.147; its P/E ratio is -3.87; CytoMed Therapeutics Limited is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 52.01K$ 290.56K$ 0.00$ 84.18K$ 44.92K
Gross Profit$ 52.38K$ 381.92K$ -81.03K$ 81.59K$ 41.43K
Operating Income$ -2.63M$ -3.20M$ -1.70M$ -1.40M$ -1.00M
EBITDA$ -1.79M$ -2.94M$ -1.10M$ -1.05M$ -776.21K
Net Income$ -1.88M$ -3.13M$ -2.27M$ -1.53M$ -1.47M
Balance Sheet
Cash & Short-Term Investments$ 3.64M$ 6.82M$ 1.18M$ 1.87M$ 703.20K
Total Assets$ 7.37M$ 9.37M$ 3.90M$ 4.51M$ 2.89M
Total Debt$ 339.20K$ 339.50K$ 3.15M$ 2.42M$ 2.26M
Net Debt$ -3.30M$ -6.48M$ 1.97M$ 553.08K$ 1.59M
Total Liabilities$ 749.76K$ 852.28K$ 3.46M$ 2.59M$ 2.53M
Stockholders' Equity$ 6.57M$ 8.52M$ 438.24K$ 1.92M$ 360.37K
Cash Flow
Free Cash Flow$ -3.01M$ -2.72M$ -1.40M$ -1.70M$ -828.43K
Operating Cash Flow$ -1.98M$ -2.68M$ -1.04M$ -1.27M$ -643.14K
Investing Cash Flow$ 494.59K$ -2.11M$ -353.37K$ -610.72K$ -371.94K
Financing Cash Flow$ -33.36K$ 8.16M$ 793.25K$ 3.09M$ 1.44M
Currency in USD

CytoMed Therapeutics Limited Earnings and Revenue History

CytoMed Therapeutics Limited Debt to Assets

CytoMed Therapeutics Limited Cash Flow

CytoMed Therapeutics Limited Forecast EPS vs Actual EPS